---
description: Literature Recommendations
---

# Precision Medicine

> * [PDFs for Precision Medicine](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/)

## 0. News/Patents of Liquid Biopsy

**关于液体活检技术的科普**

* 为何投资者对癌症ctDNA液体活检依旧“信心满满，热情高涨” - NBT解析背后原因 \( [Wechat link](https://mp.weixin.qq.com/s/XbXB8cpw1uMQMId7uIirfA) \| [Nature Biotech.](https://www.nature.com/articles/d41587-019-00022-7) \)
* 开启肿瘤早筛新纪元，液态活检蓄势待发 \( [Everhub](https://www.yinxiang.com/everhub/note/d1062a1d-14a8-4e8c-af9b-70aa808715da); [Wechat link](https://mp.weixin.qq.com/s/I_mlH_l4ORrAZS_rv9bytQ) \)
* 测序中国-2019 聚焦DNA甲基化与癌症早筛专题报告Beta版 \( [PDF](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=/Popular%20Science&mode=list) \)
* **Patents:** 2019 - Nature Biotech. - Recent patents in cancer detection \( [PDF](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=%2FBiomarker%20Panel%2FPatents&mode=list) \)

## I. Reviews of Liquid Biopsy

* 2020 Science - The biology, function, and biomedical applications of **exosomes**
* 2019 Cell - Review - The Role of **Non-coding RNAs** in Oncology
* 2018 Nature Reviews Genetics - Current and future perspectives of **liquid biopsies** in **genomics**-driven oncology
* 2018 Nat Rev Clin Oncol. - Extracellular vesicles in cancer - implications for future improvements in cancer care
* 2018 NEJM - Circulating Extracellular Vesicles in Human Disease \([翻译版](https://www.nejmqianyan.cn/article/YXQYra1704286)\)
* 2018 NEJM - Application of **Cell-free DNA** Analysis to Cancer Treatment \([翻译版](https://www.nejmqianyan.cn/article/YXQYra1706174)\)
* 2018 NEJM - Sequencing of circulating cell-free dna during **pregnancy** \([翻译版](https://www.nejmqianyan.cn/article/YXQYra1705345)\)

> [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=/Review&mode=list)

## II.  Research in Liquid Biopsy

### 1. Representative  Studies

> **Comparison of different liquid biopsy tech. :**   [**Comparison Table**](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/files/?p=/liquid%20biopsy%20tech%20comparison.pptx)\*\*\*\*

* **ctDNA - mbDNA \(**Microbiome of cfDNA\) 
  * _**2020 Nature**_ - Microbiome analyses of blood and tissues suggest cancer diagnostic approach  ****
* **ctDNA - Fragment Size** 
  * _**2019 Nature**_ - Genome-wide cell-free DNA fragmentation in patients with cancer
* **ctDNA - Mutations+** 
  * _**2020 Nature**_ - Integrating genomic features for noninvasive early lung cancer detection
  * _**2020 Science -**_ **ctDNA+PET-CT -** Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
  * _**2018 Science -**_ **ctDNA+Protein\(CancerSEEK\)** - Detection and localization of surgically resectable cancers with a multi-analyte blood test
* **ctDNA Methylation**
  * _**2020 Analysis of Oncology**_ - **Grail and CCGA Consortium -** Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
  * _**2018 Nature**_ - Sensitive tumour detection and classification using plasma cell-free DNA methylomes
* **exRNA/cfRNA**  
  * **Exosome Composition \(ERCC\)**: _**2019 Cell**_  - Reassessment of Exosome Composition
  * **cfRNA**: _**2018 Science**_ - Noninvasive blood tests for fetal development predict gestational age and preterm delivery
  * **Platelet RNA:** _**2015 Cancer Cell**_ - RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

> * [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=%2FcfDNA&mode=list) of ctDNA/cfDNA papers
> * [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=%2FcfRNA&mode=list) of exRNA/cfRNA papers

### 2. exRNA/cfRNA <a id="exRNA"></a>

* **MISC**
  * **mRNA/lncRNA fragments**: _**2019 EMBO J.**_  - Phospho‐RNA‐seq: a modified small RNA‐seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma
  * **exRNA Components**: _**2017 Nature Communication**_ - Coding and noncoding landscape of extracellular RNA
* **Lu Z.J. Lab**
  * **structured ncRNA domain \(small cfRNA-seq\)**: _**2019 Clinical chemistry**_  - Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma
  * **lncRNA:**  _**2017 Nature Communications** -_ Recurrently deregulated lncRNAs in hepatocellular carcinoma. 
  * **Prospective Review**: _**2017 Noncoding RNA**_ - RNA Biomarkers: Frontier of Precision Medicine for Cancer
* **Fudan Group \(**Shenglin Huang Lab + Peng Wang Lab**\)**
  * **long evRNA-seq**: _**2020 GUT**_ Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma
  * **long evRNA-seq**: _**2019 Clinical Chemistry**_ - Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis
  * **exoRBase:** _**2018 NAR**_ - exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes
* **Zhong S. Lab**
  * **cfRNA**: _**2020 Current Biology**_ - Presymptomatic increase of an extracellular RNA in blood plasma is associated with the development of Alzheimer’s disease
  * **SILVER-seq**: _**2019 PNAS**_ - Extracellular RNA in a single droplet of human serum reflects physiologic and disease states
* **Quake S. Lab**
  * **long cfRNA-seq**: _**2018 Science**_ - Noninvasive blood tests for fetal development predict gestational age and preterm delivery
  * **long cfRNA-seq**: _**2017 Clinical chemistry**_ - Simultaneously Monitoring Immune Response and Microbial Infections during Pregnancy through Plasma cfRNA Sequencing
* **Wurdinger T.** :  
  * **Platelet RNA:** _**2015 Cancer Cell**_ - RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
  * **Platelet RNA:** _**2017 Cancer Cell**_ - Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
* **Fan J. Lab**
  * **miRNA7**: _**2011 JCO**_ - Jia Fan - Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
* **ERCC**  \(_**2019 Cell papers**_\)
  * **exceRpt**: Cell system 2019 - exceRpt: A Comprehensive Analytic Platform for Extracellular RNA Profiling
  * **Extracellular carriers**: Cell minireview 2019 - Mapping Extracellular RNA Sheds Lights on Distinct Carriers
  * **ERCC perspective**: Cell perspective 2019 - The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research
  * **Exosome preview**: Cell preview 2019 - Explicating Exosomes: Reclassifying the Rising Stars of Intercellular Communication
  * **Exosome composition**: Cell article 2019 - Reassessment of Exosome Composition
  * **exRNA carriers**: Cell resource 2019 - exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids
  * **Small exRNA-seq**: Cell resource 2019 - Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation
  * **Exosome PD-L1**: Cell article 2019 - Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory

> * [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=/cfRNA&mode=list) of exRNA/cfRNA papers



### 3. ctDNA/cfDNA <a id="other"></a>

* **ctDNA - mbDNA \(**Microbiome of cfDNA\)
  * _**2020 Nature**_ - Microbiome analyses of blood and tissues suggest cancer diagnostic approach  ****
* **ctDNA - Fragment-Size**
  * _**2019 Nature**_ - Genome-wide cell-free DNA fragmentation in patients with cancer
* **ctDNA - Mutations+**  \( [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=/ctDNA&mode=list) \)
  * **Papadopoulos N Lab**
    * _**2020 Science -**_ **ctDNA+PET-CT -** Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
    * _**2018 Science -**_ **ctDNA+Protein\(CancerSEEK\)** - Detection and localization of surgically resectable cancers with a multi-analyte blood test
  * _**2020 Nature**_ - Integrating genomic features for noninvasive early lung cancer detection
  * _**2019 Nature Medicine**_ - Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
* **ctDNA Methylation \(** [PDF](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=/cfDNA%20Methylation&mode=list) **\)**
  * _**2020 Analysis of Oncology**_ - **Grail and CCGA Consortium -** Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
  * **chips**: _**2018 Nature**_ - DNA methylation-based classification of central nervous system tumours
  * **meDIP**: _**2018 Nature**_ - Sensitive tumour detection and classification using plasma cell-free DNA methylomes
  * **WGBS**: _**2017 Nature Genetics**_ - Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA

> * [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=%2FcfDNA&mode=list) of ctDNA/cfDNA papers

## III. exRNA-seq Technologies

### 1. Protocols & Technologies

* **Comparison**: RNA biology 2018 - Evaluation of methodologies for microRNA biomarker detection by next generation sequencing
* **Barcode**: Nature Methods 2015 - Simultaneous generation of many RNA-seq libraries in a single reaction
* **UMI**: Nature Methods 2012 - Counting absolute numbers of molecules using unique molecular identifiers, Nature Methods 2014 - Quantitative single-cell RNA-seq with unique molecular identifiers
* **SMART-seq2\(TSO\)**: Nature Protocol 2014 - Full length RNA-seq from single cells using Smart-seq2
* **Pico-seq**:
  * **DASH/CRISPR**: Genome Biology 2016 - Depletion of Abundant Sequences by Hybridization \(DASH\): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications
  * **Pico Patent**: Pico Patent Application Publication
* **SILVER-seq**: 2019 PNAS - Extracellular RNA in a single droplet of human serum reflects physiologic and disease states

> [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=/RNA-seq%20library%20technology&mode=list)

### 2. Commercial Kit 

* **V1-NEB**: E7300-NEB small RNA kit
* **V2-SMART**: SMARTer smRNA-Seq Kit for Illumina User Manual
* **V2-SMART**: SMARTer Stranded Total RNA-Seq Kit - Pico Input Mammalian User Manual
* **V3-Pico**: Long cfRNA-seq Kit
  * Clontech technology-low input RNA library kit
  * Clontech technology-pico kit

> [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=/RNA-seq%20library%20construction%20kit%20manual&mode=list)

###  <a id="drylab"></a>

## IV. Biomarker Panel Studies

> [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=/Biomarker%20Panel&mode=list)

### 1. Meta-analysis

* **protein markers**: 2016 Lancet Neurol - CSF and blood biomarkers for the diagnosis of Alzheimer's disease- a systematic review and meta-analysis
* **DNA markers**: 2014 Nat Genetics - Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk
* **lncRNA markers**: 2005 Cancer Res. - Identification of GATA3 as a Breast Cancer Prognostic Marker by Global Gene Expression Meta-analysis

### 2. Detection and Diagnosis

* **ctDNA+Protein \(CancerSEEK\)**: 2018 - Science - Detection and localization of surgically resectable cancers with a multi-analyte blood test
* **ctDNA+Protein+Clinical Info**: 2019 - PNAS - Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy

### 3. Prognosis 

* **Progosis ctDNA**: 2019 JCO - Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
* **Prognosis ctDNA**: 2019 JAMA Oncology - Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
* **Prognosis ctDNA**: 2019 Translational Med. - Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
* **Prognosis ctDNA**：2019 JAMA Oncology - Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
* **Liquid vs. tissue biopsy**： 2019 Nature Medicine - Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

## V. Cancer Immunology

* 2019 - Nat Genetics - Landscape of B cell immunity and related immune evasion in human cancers. PubMed PMID: 30742113
* 2018 - Nat Biotech - Evaluation of immune repertoire inference methods from RNA-seq data. PubMed PMID: 30412202
* 2017 - Nat Genetics - Ultrasensitive detection of TCR hypervariable-region sequences in solid-tissue RNA-seq data.
* 2016 - Nature Genetics - Landscape of tumor-infiltrating T cell repertoire of human cancers
* 2018 - JCO - Immune checkpoint molecule expression measured using circulating cell-free RNA isolated from the blood of metastatic prostate cancer patients.

